A detailed history of Advisor Group Holdings, Inc. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 23,634 shares of RLAY stock, worth $99,971. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,634
Previous 342 6810.53%
Holding current value
$99,971
Previous $2,000 8250.0%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$6.23 - $9.51 $145,109 - $221,506
23,292 Added 6810.53%
23,634 $167,000
Q2 2024

Aug 13, 2024

SELL
$5.9 - $8.02 $141,782 - $192,728
-24,031 Reduced 98.6%
342 $2,000
Q1 2024

May 10, 2024

BUY
$7.5 - $12.07 $1,065 - $1,713
142 Added 0.59%
24,373 $202,000
Q4 2023

Feb 12, 2024

SELL
$6.01 - $11.48 $276 - $528
-46 Reduced 0.19%
24,231 $266,000
Q3 2023

Nov 13, 2023

SELL
$8.24 - $12.97 $123 - $194
-15 Reduced 0.06%
24,277 $204,000
Q2 2023

Aug 10, 2023

SELL
$9.99 - $18.27 $869 - $1,589
-87 Reduced 0.36%
24,292 $305,000
Q1 2023

May 12, 2023

BUY
$15.0 - $22.76 $900 - $1,365
60 Added 0.25%
24,379 $401,000
Q4 2022

Feb 10, 2023

SELL
$14.16 - $24.02 $467 - $792
-33 Reduced 0.14%
24,319 $363,000
Q3 2022

Nov 14, 2022

BUY
$18.07 - $31.37 $2,692 - $4,674
149 Added 0.62%
24,352 $544,000
Q2 2022

Aug 10, 2022

SELL
$13.31 - $34.88 $322,102 - $844,096
-24,200 Reduced 50.0%
24,203 $405,000
Q1 2021

May 13, 2021

BUY
$32.52 - $61.53 $1.57 Million - $2.98 Million
48,403 New
48,403 $1.67 Million

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $509M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Advisor Group Holdings, Inc. Portfolio

Follow Advisor Group Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.